Accelerate Diagnostics (AXDX) Reports Q1 Loss, Misses Revenue EstimatesZacks Investment Research • 05/08/24
Will Accelerate Diagnostics (AXDX) Report Negative Q1 Earnings? What You Should KnowZacks Investment Research • 05/02/24
Accelerate Diagnostics (AXDX) Reports Q4 Loss, Misses Revenue EstimatesZacks Investment Research • 03/28/24
Accelerate Diagnostics Reports Fourth Quarter and Full-Year 2023 Financial ResultsPRNewsWire • 03/28/24
Accelerate Diagnostics Scheduled Call to Review 2023 Fourth Quarter and Full Year Results.PRNewsWire • 03/07/24
Accelerate Diagnostics Announces Pricing of Approximately $15 Million Public Offering and Private PlacementPRNewsWire • 01/19/24
Accelerate Diagnostics Announces Certain Preliminary Fourth Quarter and Full-Year 2023 ResultsPRNewsWire • 01/08/24
Accelerate Diagnostics Announces Collaboration for the Use of the Arc™ System in Combination With Bruker´s MALDI Biotyper®PRNewsWire • 11/27/23
Accelerate Diagnostics (AXDX) Loses -25.65% in 4 Weeks, Here's Why a Trend Reversal May be Around the CornerZacks Investment Research • 11/22/23
Accelerate Diagnostics (AXDX) Moves 12.7% Higher: Will This Strength Last?Zacks Investment Research • 10/03/23
Accelerate Diagnostics (AXDX) Reports Q2 Loss, Misses Revenue EstimatesZacks Investment Research • 08/10/23